中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
中国医药(600056) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入826,274.463,414,835.962,609,973.001,779,732.22877,484.59
营业收入826,274.463,414,835.962,609,973.001,779,732.22877,484.59
二、营业总成本797,344.553,298,344.522,521,678.361,715,329.11851,387.64
营业成本738,733.293,048,959.392,331,705.861,585,603.33787,133.41
营业税金及附加2,748.939,823.496,875.394,594.442,294.12
销售费用24,263.03109,922.5983,616.4758,938.6730,264.94
管理费用24,508.5797,524.7077,749.1450,953.9924,079.03
财务费用3,738.9019,592.3712,756.218,870.404,366.89
研发费用3,351.8312,521.988,975.296,368.273,249.25
资产减值损失----------
公允价值变动收益15.4812,746.69-110.85-110.85-44.31
投资收益755.91-6,501.68500.27131.06365.17
其中:对联营企业和合营企业的投资收益1,616.221,873.563,514.932,314.931,090.53
汇兑收益----------
三、营业利润30,465.0993,156.7985,056.4760,665.2727,553.22
加:营业外收入274.974,525.44976.64671.8492.33
减:营业外支出278.692,363.371,754.73934.73288.94
其中:非流动资产处置损失----------
四、利润总额30,461.3695,318.8584,278.3860,402.3827,356.61
减:所得税费用7,741.3626,656.4622,186.5815,426.717,068.53
五、净利润22,720.0068,662.3962,091.8044,975.6820,288.08
归属于母公司所有者的净利润16,637.9253,546.7744,714.8332,511.9014,560.00
少数股东损益6,082.0815,115.6217,376.9712,463.775,728.09
六、每股收益
基本每股收益(元/股)0.11120.35800.29890.21730.0973
稀释每股收益(元/股)0.11120.35800.29890.21730.0973
七、其他综合收益88.50-36.25-354.53-145.72136.15
八、综合收益总额22,808.5068,626.1461,737.2744,829.9620,424.23
归属于母公司所有者的综合收益总额16,726.4253,508.3744,360.3132,366.1914,696.14
归属于少数股东的综合收益总额6,082.0815,117.7717,376.9712,463.775,728.09
下载全部历史数据到excel中 返回页顶